Inovio Pharmaceuticals Inc. Stock Rallies 4.3%, Outperforms Peers
Dow Jones2026/10/28 20:35This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Inovio Pharmaceuticals Inc. advanced 4.3% to $0.93 on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index rising 0.3% to 26,549.85 and the Dow Jones Industrial Average rising 0.2% to 52,475.10.
This was the stock's second consecutive day of gains.
Inovio Pharmaceuticals Inc. closed 65.9% below its 52-week high of $2.72, which the company reached on December 17th.
The stock outperformed some of its peers, as Johnson & Johnson rose 0.9% to $271.04, Statera Biopharma Inc. remained unchanged, and Pfizer Inc. fell 1.17% to $29.45.
Trading volume totaled 4.5 million, compared to the 50-day average of 3.6 million.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
October 28, 2026 16:35 ET (20:35 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Barclays: Bloom Energy (BE.US) demand turning point is steeper than expected, rating raised to "Buy"
Barclays has upgraded Bloom Energy’s rating from "equal weight" to "overweight," setting a target price of $289.
Competitor turns supplier as the "new owner"! Bank of America: Marvell Technology's acquisition of Lumentum may prompt Cisco and Ciena to seek other sources
Bank of America analysts stated that Marvell Technology's acquisition of Lumentum may prompt Ciena and Cisco to diversify their optical component suppliers.
Goldman Sachs traders warn of an "invisible bear market": S&P 500 is only 3% away from its all-time high, but 60% of its constituent stocks have entered bear market territory.
The S&P 500 Index is only about 3% away from its latest record high, but 60% of the constituent stocks in this benchmark index are deeply entrenched in bear market territory.
Crypto prices
More
